These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 32547104)
1. LncRNA XIST Promotes Growth of Human Chordoma Cells by Regulating miR-124-3p/iASPP Pathway. Hai B; Pan X; Du C; Mao T; Jia F; Liu Y; Ma Y; Liu X; Zhu B Onco Targets Ther; 2020; 13():4755-4765. PubMed ID: 32547104 [TBL] [Abstract][Full Text] [Related]
2. Downregulation of lncRNA XIST promotes proliferation and differentiation, limits apoptosis of osteoblasts through regulating miR-203-3p/ZFPM2 axis. Niu S; Xiang F; Jia H Connect Tissue Res; 2021 Jul; 62(4):381-392. PubMed ID: 32326773 [No Abstract] [Full Text] [Related]
3. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells. Qiu HB; Yang K; Yu HY; Liu M Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569 [TBL] [Abstract][Full Text] [Related]
4. XIST sponges miR-320d to promote chordoma progression by regulating ARF6. Wang Y; Tang Z; Guo W J Bone Oncol; 2022 Aug; 35():100447. PubMed ID: 35899235 [TBL] [Abstract][Full Text] [Related]
5. LncRNA XIST Contributes to Cisplatin Resistance of Lung Cancer Cells by Promoting Cellular Glycolysis through Sponging miR-101-3p. Hua G; Zeng ZL; Shi YT; Chen W; He LF; Zhao GF Pharmacology; 2021; 106(9-10):498-508. PubMed ID: 34352791 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of XIST facilitates cell proliferation, invasion and suppresses cell apoptosis by reducing radio-sensitivity of glioma cells via miR-329-3p/CREB1 axis. Wang YP; Li HQ; Chen JX; Kong FG; Mo ZH; Wang JZ; Huang KM; Li XN; Yan Y Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3190-3203. PubMed ID: 32271437 [TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA XIST expedites lung adenocarcinoma progression through upregulating MDM2 expression via binding to miR-363-3p. Rong H; Chen B; Wei X; Peng J; Ma K; Duan S; He J Thorac Cancer; 2020 Mar; 11(3):659-671. PubMed ID: 31968395 [TBL] [Abstract][Full Text] [Related]
8. GINS2 was regulated by lncRNA XIST/miR-23a-3p to mediate proliferation and apoptosis in A375 cells. Hao YQ; Liu KW; Zhang X; Kang SX; Zhang K; Han W; Li L; Li ZH Mol Cell Biochem; 2021 Mar; 476(3):1455-1465. PubMed ID: 33389496 [TBL] [Abstract][Full Text] [Related]
9. Long Noncoding RNA X-Inactive-Specific Transcript Promotes the Secretion of Inflammatory Cytokines in LPS Stimulated Astrocyte Cell Via Sponging miR-29c-3p and Regulating Nuclear Factor of Activated T cell 5 Expression. Zhang M; Yang H; Chen Z; Hu X; Wu T; Liu W Front Endocrinol (Lausanne); 2021; 12():573143. PubMed ID: 33776905 [TBL] [Abstract][Full Text] [Related]
10. Long Non-Coding RNA MDFIC-7 Promotes Chordoma Progression Through Modulating the miR-525-5p/ARF6 Axis. Zhang K; Liu Z; Wang Z; Zhou Z; Shao X; Hua X; Mao H; Yang H; Ren K; Chen K Front Oncol; 2021; 11():743718. PubMed ID: 34621682 [TBL] [Abstract][Full Text] [Related]
11. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo. Shi J; Tan S; Song L; Song L; Wang Y Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117 [TBL] [Abstract][Full Text] [Related]
12. LncRNA XIST promotes carboplatin resistance of ovarian cancer through activating autophagy via targeting miR-506-3p/FOXP1 axis. Xia X; Li Z; Li Y; Ye F; Zhou X J Gynecol Oncol; 2022 Nov; 33(6):e81. PubMed ID: 36335987 [TBL] [Abstract][Full Text] [Related]
13. lncRNA XIST/miR‑129‑2‑3p axis targets CCP110 to regulate the proliferation, invasion and migration of endometrial cancer cells. Chen S; Liang Y; Shen Y; Wang X Exp Ther Med; 2023 Apr; 25(4):159. PubMed ID: 36911384 [TBL] [Abstract][Full Text] [Related]
14. LncRNA XIST regulates myocardial infarction by targeting miR-130a-3p. Zhou T; Qin G; Yang L; Xiang D; Li S J Cell Physiol; 2019 Jun; 234(6):8659-8667. PubMed ID: 29226319 [TBL] [Abstract][Full Text] [Related]
15. Knockdown of lncRNA XIST inhibits hypoxia-induced glycolysis, migration and invasion through regulating miR-381-3p/NEK5 axis in nasopharyngeal carcinoma. Zhao CH; Bai XF; Hu XH Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2505-2517. PubMed ID: 32196601 [TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA XIST confers aggressive progression via miR-361-3p/STX17 in retinoblastoma cells. Yang LL; Li Q; Zhang X; Cao T Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10433-10444. PubMed ID: 33155266 [TBL] [Abstract][Full Text] [Related]
17. Downregulating LncRNA XIST attenuated contrast-induced nephropathy injury via regulating miR-133a-3p/NLRP3 axis. Liu X; Song W; Zhang X; Long F; Yin J; He X; Lv L J Thromb Thrombolysis; 2021 Aug; 52(2):440-453. PubMed ID: 33387208 [TBL] [Abstract][Full Text] [Related]
18. LncRNA XIST Protects Against Polycystic Ovary Syndrome via the Regulation of miR-212-3p/RASA1 Axis. Xu X; Yin C; Dong B; Li Y; Liu S; Chen J Biochem Genet; 2024 Apr; ():. PubMed ID: 38609670 [TBL] [Abstract][Full Text] [Related]
19. Long Noncoding RNA XIST Contributes to Cervical Cancer Development Through Targeting miR-889-3p/SIX1 Axis. Liu X; Xie S; Zhang J; Kang Y Cancer Biother Radiopharm; 2020 Nov; 35(9):640-649. PubMed ID: 32191528 [No Abstract] [Full Text] [Related]
20. The lncRNA XIST interacts with miR-140/miR-124/iASPP axis to promote pancreatic carcinoma growth. Liang S; Gong X; Zhang G; Huang G; Lu Y; Li Y Oncotarget; 2017 Dec; 8(69):113701-113718. PubMed ID: 29371940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]